← Leaderboards
Lara M Mangravite
Mayo Clinic Jacksonville
$9,274,560
Attributed
$17,194,497
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $15.4M · FY2016–22$20M$15M$10M$5M$0
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$54,912,411 · 7
By mechanism
U54$22,230,909 · 1
U2C$15,487,005 · 2
U24$7,371,635 · 1
RF1$6,515,676 · 2
U01$3,307,186 · 1
Top collaborators
- Richard Gershon9 shared
- Dorene May Rentz9 shared
- Michael W Weiner9 shared
- Aaron James Kaat6 shared
- Paul Brennan5 shared
- Earl Ray Dorsey5 shared
- Nathan D Price5 shared
- Eric E Schadt5 shared
Most similar at Mayo Clinic Jacksonville
Same institution · by research overlap
- Nilufer Ertekin-Taner$28,054,444
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposResourcesResearch PersonnelDesignS DiseaseValidationBasePreventProgramsCommunitiesUnited States National Institutes Of HealthEvaluationSamplingMedicineBiologicalCellular PhoneCohortMeasurementParkinson DiseaseBiological MarkersOpen DataMonitorPersonsPatient Outcomes Assessments
Grant awards (35)
Data Coordination for the AMP Autoimmune and Related (AR) Knowledge Portal Part B$1,020,000
U24 · FY2022 · AG · contact PI
Advancing Image Data Interoperability and Standards within an NIH Ecosystem (AIDISNE): A CHOP, FlyWheel, and Seven Bridges Integration Demonstration Project$911,876
U2C · FY2022 · HL
The MobileToolbox for Monitoring Cognitive Function$423,675
U2C · FY2022 · AG
Expanding data from diverse cohorts in the AD Knowledge Portal$168,480
U24 · FY2022 · AG · contact PI
Open Drug Discovery Center for Alzheimer's Disease$7,311,958
U54 · FY2021 · AG
The MobileToolbox for Monitoring Cognitive Function$2,257,621
U2C · FY2021 · AG
Tele-Health Extension for Phase 3 Parkinson's Disease Trial Cohorts$778,151
U01 · FY2021 · NS
The MobileToolbox for Monitoring Cognitive Function$422,164
U2C · FY2021 · AG
Data Coordination for the AMP Autoimmune and Related (AR) Knowledge Portal$408,537
U24 · FY2021 · AG · contact PI
User-ready tools and scalable workflows for INCLUDE datasets in the cloud: advancing brain imaging data management and analytics$273,575
U2C · FY2021 · HL
Open Drug Discovery Center for Alzheimer's Disease$7,420,073
U54 · FY2020 · AG
The MobileToolbox for Monitoring Cognitive Function$3,757,281
U2C · FY2020 · AG
AMP-AD Data Coordination Center$1,417,076
U24 · FY2020 · AG · contact PI
Enhancing access to multi-omic data assets in the AMP-AD research ecosystem$1,020,000
U24 · FY2020 · AG · contact PI
Tele-Health Extension for Phase 3 Parkinson's Disease Trial Cohorts$786,024
U01 · FY2020 · NS
The MobileToolbox for Monitoring Cognitive Function$424,401
U2C · FY2020 · AG
Open Data from the Exceptional Longevity Program$216,747
U24 · FY2020 · AG · contact PI
Framework for a series of high priority multiscale analyses$156,188
U24 · FY2020 · AG · contact PI
Open Drug Discovery Center for Alzheimer's Disease$7,498,878
U54 · FY2019 · AG
The MobileToolbox for Monitoring Cognitive Function$3,751,041
U2C · FY2019 · AG
AMP-AD Data Coordination Center$1,265,279
U24 · FY2019 · AG · contact PI
Tele-Health Extension for Phase 3 Parkinson's Disease Trial Cohorts$790,164
U01 · FY2019 · NS
The MobileToolbox for Monitoring Cognitive Function$699,993
U2C · FY2019 · AG
AMP-AD Data Coordination Center Supplement - Lowering Barriers of Access and Use: Framingham Generation 1 Brain Aging Data$414,956
U24 · FY2019 · AG · contact PI
Adding RDoC Measures to the MobileToolbox$314,569
U2C · FY2019 · AG
Validation of Antibody Reagents for 15 High Priority AMP-AD Targets$287,500
RF1 · FY2019 · AG · contact PI
Expanding Target Enabling Packages for AMP-AD Target Validation to identify small molecule inhibitors that block protein-protein interactions in cells$252,472
RF1 · FY2019 · AG · contact PI
Tele-Health Extension for Phase 3 Parkinson's Disease Trial Cohorts$100,000
U01 · FY2019 · NS
The MobileToolbox for Monitoring Cognitive Function$2,250,809
U2C · FY2018 · AG
Infrastructure to improve reliability of AMP-AD target hypotheses$1,885,852
RF1 · FY2018 · AG · contact PI
AMP-AD Data Coordination Center$1,284,372
U24 · FY2018 · AG · contact PI
Tele-Health Extension for Phase 3 Parkinson's Disease Trial Cohorts$852,847
U01 · FY2018 · NS
Expanding AMP-AD Target Enabling Packages to identify small molecule inhibitors that block protein-protein interaction$202,186
RF1 · FY2018 · AG · contact PI
Open systems for AMP-AD target enhancement$3,390,271
RF1 · FY2017 · AG · contact PI
Integrative translational discovery of vascular risk factors in aging and dementia$497,395
RF1 · FY2016 · AG